COMPOSITION:
rabeprazole 10 mg
INDICATION:
Gastroesophageal reflux disease (GERD)
Gastric and duodenal ulcers
Prevention of recurrence of (NSAID)- associated gastric ulcers
Reducing the risk of duodenal ulcer recurrence associated with H. pylori infections.
DOSAGE:
Gastric ulcer
– 20 mg OD in the morning for 6 weeks
– Continued for further 6 weeks if not fully healed
GERD
– 20 mg OD for 4 to 8 weeks
– Maintenance : 10 to 20 mg daily
AVAILABILTY: IN STOCK
MANUFACTURER:
Stallion Laboratories PVT.LTD
